Logo Logo
Help
Contact
Switch Language to German

Rule, S.; Jurczak, W.; Jerkeman, M.; Rusconi, C.; Trneny, M.; Offner, F.; Caballero, D.; Joao, C.; Witzens-Harig, M.; Hess, G.; Bence-Bruckler, I.; Cho, S-G; Thieblemont, C.; Zhou, W.; Henninger, T.; Goldberg, J.; Vermeulen, J. and Dreyling, M. (2018): Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study. In: Leukemia, Vol. 32, No. 8: pp. 1799-1803

Full text not available from 'Open Access LMU'.

Actions (login required)

View Item View Item